Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06291207

A Study to Evaluate the Efficacy and Safety of AD-224

Conditions: Hypertension,Essential

Sex: All

Ages: 19 Years – N/A

Healthy volunteers: No

Phase: PHASE3

Enrollment: 254

Sponsor: Addpharma Inc.

Location: Seoul National University Bundang Hospital Seongnam-si

Summary

The purpose of this study is to evaluate the efficacy and safety of AD-224

Eligibility Criteria

Inclusion Criteria: * Signed informed consent * Patients with Essential Hypertension * Other inclusions applied Exclusion Criteria: * Patient with Secondary Hypertension * Other exclusions applied

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06291207). StuddyBuddy aggregates publicly available trial information.